BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16834821)

  • 1. Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.
    Schwab AE; Churcher TS; Schwab AJ; Basáñez MG; Prichard RK
    Parasitology; 2006 Nov; 133(Pt 5):589-601. PubMed ID: 16834821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy.
    Schwab AE; Churcher TS; Schwab AJ; Basáñez MG; Prichard RK
    Parasitology; 2007 Jul; 134(Pt 7):1025-40. PubMed ID: 17320006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J
    Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment.
    Schwab AE; Boakye DA; Kyelem D; Prichard RK
    Am J Trop Med Hyg; 2005 Aug; 73(2):234-8. PubMed ID: 16103581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An allele specific PCR assay for screening for drug resistance among Wuchereria bancrofti populations in India.
    Hoti SL; Dhamodharan R; Subramaniyan K; Das PK
    Indian J Med Res; 2009 Aug; 130(2):193-9. PubMed ID: 19797818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
    de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
    Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of a chemotherapy effect on the cuticular surface of Wuchereria bancrofti adult worms in vivo.
    Oliveira-Menezes A; Lins R; Norões J; Dreyer G; Lanfredi RM
    Parasitol Res; 2007 Oct; 101(5):1311-7. PubMed ID: 17622561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
    Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
    J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
    Sankari T; Subramanian S; Hoti SL; Pani SP; Jambulingam P; Das PK
    Parasitol Res; 2021 Jan; 120(1):311-319. PubMed ID: 33146778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
    de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
    Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children.
    Fox LM; Furness BW; Haser JK; Desire D; Brissau JM; Milord MD; Lafontant J; Lammie PJ; Beach MJ
    Am J Trop Med Hyg; 2005 Jul; 73(1):115-21. PubMed ID: 16014845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T; Ismid IS; Rückert P; Fischer P
    Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
    Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
    Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
    Rizzo JA; Belo C; Lins R; Dreyer G
    Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
    Addiss DG; Beach MJ; Streit TG; Lutwick S; LeConte FH; Lafontant JG; Hightower AW; Lammie PJ
    Lancet; 1997 Aug; 350(9076):480-4. PubMed ID: 9274584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
    Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
    Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.